Multimorbidity in elderly rheumatic patients part 1;Multimorbidität bei älteren Rheumapatienten Teil 1

Zeitschrift fur Rheumatologie

Volumn 72, Issue 6, 2013, Pages 530-538

  Lakomek, H J ^a   Brabant, T ^b   Lakomek, M ^a   Luttje D ^c  

^a KLINIKUM MINDEN   (Germany)

^b Zentrum für Geriatrie   (Germany)

^c Andreas Bannowsky Ltd   (Germany)

Author keywords

Comorbidity; Frailty; Immobility; Osteoporosis; Sarkopenia

Indexed keywords

AGE; ARTICLE; FRAIL ELDERLY; HUMAN; IMMOBILIZATION; IMMUNOSUPPRESSIVE TREATMENT; MALNUTRITION; MORBIDITY; RHEUMATIC DISEASE;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEMALE; GERIATRIC ASSESSMENT; HUMANS; KIDNEY DISEASES; MALE; RHEUMATIC DISEASES;

EID: 84882448613     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-012-1115-4     Document Type: Article

References (54)

1. Bauer JM (2008) Malnutrition sarkopenia and cachexia in the elderly: from pathophysiology to treatment. Conclusion of an international meeting of experts, sponsered by the BAnss foundation. Dtsch Med Wochenschr 133:305-310
2. Blain A, Vuillememin A et al (2001) Influence of muscle strength and body weight and composition on regional bone mineral density in healthy women aged 60 years and over. Gerontology 47(4):207-212
3. Braithwaite RS, Col NF, Wong J (2003) Estimating hip fracture morbidity, mortality and costs. J Am Ger Soc 51:364-370
4. Busche H van den, Scherer M (2011) Das Verbundvorhaben Komorbidität und Multimorbidität in der hausärztlichen Versorgung. Z Gerontol Geriatr 44:73-100
5. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The colorado thyroid disease prevalence study. Arch Intern Med 160:526-534
6. Clegg A, John Y (2011) The frailty syndrome. Clin Med 11(1):72-74
7. Confavreux CB, Charpurlat RD (2011) Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis. Osteoporos Int 22(4):1023-1036
8. David JP, Schett G (2010) TNF and bone. Curr Dir Autoimmun 11:135-144
9. Drey M, Kaiser MJ (2011) Mangelernährung im Alter. Dtsch Med Wochenschr 126:176-178
10. De Groot K, Märker-Hermann E (2011) Behandlung der Komorbiditäten entzündlich-rheumatischer Erkrankungen. Internist 52:688-696
11. Flodin L, Swensson S, Cederholm T (2000) Body mass index as a predictorof 1 year mortality in geriatric patient. Clin Nutr 19:121-125
12. Frischknecht R (1998) Effect of training on muscle strength and motor function in the elderly. Reprod Nutr Dev 38:167-174
13. Fuchs J, Busch M, Lange C, Scheidt-Nave C (2012) Prevalence and patterns of morbidity among adults in Germany. Bundesgesundheitsblatt 55:576-586
14. Goodsson N (2002) Coronary artery diesease and rheumatoid arthritis. Curr Opin Rheumatol 14:115-120
15. Groß P (2009) Von Selbstständigkeit zu Abhängigkeit - das Frailty-Syndrom. Arthritis Rheuma 29:13-16
16. Guigoz Y, Yellas B, Garry PJ (1996) Assessing the nutritional status oft the elderly: the Mini Nutritional Assessment a spart of geriatric evaluation. Nutr Rev 54:59-64
17. Huscher D, Sengler C, Gromnica-Ihle E et al (2013) Clinical presentation, burden of disease and treatment in young-onset and late-onset rheumatoid arthritis: a matched-pairs analysis taking age and disease duration into account. Clin Exp Rheumatol 31:256-262
18. Jaspers C, Lakomek HJ (2009) Osteoporosebehandlung im höheren Lebensalter. Arthritis Rheuma 29:31-36
19. Kitas GD, Gabriel SE (2011) Cardiovaskular disease risk in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 70:8-14
20. Kortebein P, Ferrando A, Lombeida J et al (2007) Effect on ten days of bed rest on skeletal muscle in healthy older adults. JAMA 297:1772-1774
21. Kuhlmey A (2009) Spezielle Versorgungsanforderungen bei älteren und alten Menschen. Z Gerontol Geriatr 42:425-431
22. Lakomek H-J (2006) Brauchen wir eine stationäre Rheumatologie. Dtsch Med Wochenschr 131:2292-2294
23. Lakomek H-J, Krause A (2011) "Treat-to-Target" (T2T) aus der Sicht der stationären Rheumatologie. Z Rheumatol 70:656-663
24. Lucke C, Krause D, Lüttje D (2000) Die Betreuung von Patienten im hohen Lebensalter durch den Internisten in der Praxis. Internist 41:563-572
25. Maradit-Kremers H, Nicola PJ, Crowsons CS et al (2005) Cardiovascular death in rheumatoid arthritis; a population-based study. Arthritis Rheum 52:722-732
26. McCoy S, Crowson CS, Gabriel SE, Matteson EL (2012) Hypothyreoidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. J Rheumatol 39:5. doi:10,3899/jrheum.111076
27. Moulias RZ, Meaume S, Raynaud-Simon A (1999) Sarcopenia hypermetabolisme and aging. Gerontol Geriatr 32:425-432
28. Mühlberg W, Sieber C (2004) Sarcopenia und frailty in geriatric patient; implications for training und prevention. Z Gerontol Geriatr 37(1):2-8
29. Ochs N, Auer R, Bauer DC et al (2008) Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 148:832-845
30. o A (1998) Osteoporosis: review oft he evidence for prevention, diagnosis and treatment and costeffectiveness analysis. Status report developed by the National Osteoporosis Foundation. Osteoporos Int 8(Suppl 4)
31. Parle JV, Maisonneuve P, Sheppard MC et al (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861-865
32. Rall C, Roubenoff R (2004) Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology 43:1219-1223
33. Raterman HG, Halm VP van, Voskuyl AE (2008) Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk. An Rheum Dis 67:229-232
34. Rauner M, Hofbauer LC, Aringer M (2012) Lokale und systemische Knocheneffekte bei rheumatoider Arthritis. Z Rheumatol 71:869-874
35. Redlich K, Hayer S, Ricci R et al (2002) Osteoclasts are essential for TNF a mediated joint destruction. J Clin Invest 110(10):1419-1427
36. Schäffler A (2010) Hormone replacement after thyroid and parathyroid surgery. Dtsch Ärztebl Int 107(47):827-834. doi:10.3238/arztebl.2010.0827
37. Scheidt-Nave C, Richter S, Fuchs J, Kuhlmey A (2010) Herausforderungen an die Gesundheitsforschung für eine alternde Gesellschaft am Beispiel "Multimorbidität". Bundesgesundheitsblatt 53:441-450
38. Schüz B, Dräger D, Richter S et al (2011) Autonomie trotz Multimorbidität im Alter - Der Berliner Forschungsbund AMA. Z Gerontol Geriatr 44(Suppl 2):9-25
39. Shiroky JB, Cohen M, Ballachey ML, Neville C (1993) Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis 52:454-456
40. Sieber C (2012) Sarcopenia und Frailty. In: Cruz-Jentoft AJ, Morley J (Hrsg) Sarcopenia. Wiley & Blackwell, (11), S 154-168
41. Smolen JS, Aletaha D, Bijlsma JWJ et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69:631-637
42. Solomon DH, Curhan GC, Rimm EB et al (2004) Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 50:3444-3449
43. Solomon DH, Kremer J, Curtis JR et al (2010) Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 69:1920-1925
44. Summers GD, Deighon CM et al (2008) Rheumatoid cachexia: a clinical perspective. Rheumatology 47:1124-1131
45. Thiem U, Hinrichs T, Müller CA et al (2011) Voraussetzungen für ein neues Versorgungsmodell für ältere Menschen mit Multimorbidität. Z Gerontol Geriatr 44(Suppl 2):101-112
46. Trivalle C, Doucet J, Chassagne P et al (1996) Differences in the signs and symptoms of hyperthyreoidism in older and younger patients. J Am Geriatr Soc 44:50-53
47. Van den Akker M, Van den Buntinx F, Knottnerus JA (1996) Comorbidity or multimorbidity: what's in a name. A review of literature. Eur J Gen Pract 2:65-70
48. Visser M, Kiel DP et al (1998) Muscle mass and fat mass in relation to bone mineral density in very old man and women. The Framingham heart study. Appl Radiat Isot 48:745-747
49. Völzke H, Lüdemann J, Robinson DM et al (2003) The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 13(8):803-810
50. Westhoff G, Weber C, Zink A (2006) Komorbidität bei früher rheumatoider arthritis. Z Rheumatol 65:487-496
51. Westlake S, Colebatch A, Baird J et al (2011) Tumor necrosis factor antagonists and the risk of cardiovascular disease in patient with rheumatoid arthritis: a systematic literature review. Rheumatology 50:518-531
52. o A (o J) http://www.g-ba.de
53. o A (o J) http://www.mna-elderly.com
54. Yao X, Li H et al (2011) Inflammation and immunsystem systems alterations in frailty. Clin Geriatr Med 27:79-87